ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership $17.19 -0.37 (-2.11%) Closing price 03/10/2025 04:00 PM EasternExtended Trading$17.10 -0.10 (-0.55%) As of 03/10/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$2.76 M Get ACAD Insider Trade Alerts Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACAD Insider Buying and Selling by Quarter Remove Ads ACADIA Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/5/2025Elizabeth A GarofaloDirectorSell4,919$18.23$89,673.37 2/24/2025James KiharaInsiderSell475$19.96$9,481.00 2/24/2025Mark C SchneyerCFOSell773$19.96$15,429.08 11/19/2024Brendan TeehanCOOSell10,329$16.81$173,630.49 11/19/2024James KiharaInsiderSell4,073$16.81$68,467.13 11/19/2024Mark C SchneyerCFOSell10,259$16.81$172,453.79 8/19/2024Brendan TeehanCOOSell9,534$15.28$145,679.52 8/19/2024Mark C SchneyerCFOSell9,733$15.28$148,720.24 8/19/2024Stephen DavisCEOSell31,747$15.28$485,094.16 6/10/2024Mark C SchneyerCFOSell975$14.79$14,420.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.38 5/2/2024James KiharaInsiderSell1,326$16.94$22,462.44 5/2/2024Mark C SchneyerCFOSell3,503$16.94$59,340.82 5/2/2024Stephen DavisCEOSell11,427$16.94$193,573.38 4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.16 4/8/2024James KiharaInsiderSell1,790$17.87$31,987.30 4/8/2024Mark C SchneyerCFOSell2,716$17.87$48,534.92 4/8/2024Stephen DavisCEOSell26,574$17.87$474,877.38 3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.00 3/27/2024Mark C SchneyerCFOSell5,434$17.90$97,268.60 3/27/2024Stephen DavisCEOSell17,714$17.90$317,080.60 (Data available from 1/1/2013 forward) ACAD Insider Trading Activity - Frequently Asked Questions Who is on ACADIA Pharmaceuticals's Insider Roster? The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, Elizabeth A Garofalo, James Kihara, Laura Brege, Mark C Schneyer, Srdjan R Stankovic, and Stephen Davis. Learn more on insiders at ACAD. What percentage of ACADIA Pharmaceuticals stock is owned by insiders? 28.30% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings. Which ACADIA Pharmaceuticals insiders have been buying company stock? The following insider purchased ACAD shares in the last 24 months: Bros. Advisors Lp Baker ($5,312,036.73). How much insider buying is happening at ACADIA Pharmaceuticals? Insiders have purchased a total of 209,053 ACAD shares in the last 24 months for a total of $5,312,036.73 bought. Which ACADIA Pharmaceuticals insiders have been selling company stock? The following insiders have sold ACAD shares in the last 24 months: Austin D Kim ($423,002.66), Brendan Teehan ($1,043,653.09), Elizabeth A Garofalo ($89,673.37), James Kihara ($501,716.73), Laura Brege ($111,915.00), Mark C Schneyer ($1,384,497.10), and Stephen Davis ($6,589,974.51). How much insider selling is happening at ACADIA Pharmaceuticals? Insiders have sold a total of 455,269 ACADIA Pharmaceuticals shares in the last 24 months for a total of $10,144,432.46 sold. ACADIA Pharmaceuticals Key ExecutivesMr. Stephen R. Davis J.D. (Age 63)President, CEO & Director Compensation: $1.46MMr. Mark C. Schneyer (Age 49)Executive VP & CFO Compensation: $701.03k2 recent tradesMr. Brendan P. Teehan (Age 55)Executive VP, COO & Head of Commercial Compensation: $724.31k1 recent tradesMr. James K. Kihara (Age 43)VP, Chief Accounting Officer & Corporate Controller 2 recent tradesDr. Elizabeth H.Z. Thompson Ph.D. (Age 48)Executive VP & Head of Research and Development Mr. Benir RuanoSenior Vice President of Technical Development & OperationsMr. Albert S. KildaniSenior Vice President of Investor Relations & Corporate CommunicationsMs. Jennifer J. Rhodes J.D. (Age 54)Executive VP, Chief Legal Officer & Secretary Ms. Julie FisherSenior Vice President of Marketing & Commercial StrategyMs. Holly ValdiviezSenior VP & Head of Sales More Insider Trading Tools from MarketBeat Related Companies Moderna Insider Trades Viatris Insider Trades Sarepta Therapeutics Insider Trades Vaxcyte Insider Trades Roivant Sciences Insider Trades Lantheus Insider Trades Revolution Medicines Insider Trades BridgeBio Pharma Insider Trades Axsome Therapeutics Insider Trades Grifols Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in January This page (NASDAQ:ACAD) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACAD Stock Alerts